Dados do Trabalho

Título

Unraveling Phenotypes in Brazilian Patients with Cutaneous Porphyrias: The Impact of Next Generation Sequencing with a Targeted Gene Panel

Introdução

Cutaneous porphyrias are a heterogeneous group of both acquired and genetic disorders whose diagnosis rely on clinical features and specific biochemical testing. In Brazil, biochemical testing for acute porphyrias become more accessible in the last years, nevertheless the same was not seen for cutaneous porphyrias, so most of the key laboratory testing are performed only abroad, increasing the costs for analysis. In this context, Next Generation Sequencing (NGS) became an important tool in the investigation of patients with genetic cutaneous porphyrias.

Objetivo

To report the findings of a genetic comprehensive analysis performed in Brazilian patients with clinical and/or biochemical features of cutaneous porphyrias

Métodos

Prospective data of 50 Brazilian patients with suspicion of a genetic cutaneous porphyria were collected by a national referral center for rare diseases over a 2-year period. Extracted DNA samples were analyzed using a short-read next-generation sequencing gene panel.

Resultados

Mutations were identified in 45 patients. All patients with clinical features of erythropoietic protoporphyria (EPP) showed a FECH mutation on one allele trans to a hypomorphic FECH IVS3-48C allele, being classified as having pseudodominant EPP. No compound heterozygotes (recessive EPP) neither ALAS2 mutations were identified in our patients. Biallelic UROS mutations were present in three unrelated patients with features of Congenital Erythropoietic Porphyria (CEP). No UROD mutations were found in 3 patients with a strong family history for Porphyria Cutanea Tarda (PPOX and CPOX mutations were not identified as well). Two pediatric patients born to unrelated families showed biallelic mutations in UROD gene, confirming the diagnosis of hepatoerythropoietic porphyria (HEP) – one of the patients had a previous diagnosis of CEP and was referred for bone marrow transplant that was put on hold after the genetic diagnosis.

Conclusões

This is the first report describing genetic variants for all cutaneous porphyrias in a sample of Brazilian patients. A genetic diagnosis allowed not only family genetic counseling but also changes in the management of patients whose clinical features could overlap, such as HEP and attenuated CEP patients. Our results also suggest that a comprehensive clinical history and physical exam can better guide the genetic testing, avoiding unnecessary and expensive laboratory tests which many times become a barrier to families in the pursuit of a rare disease diagnosis.

Palavras chave

Cutaneous Porphyrias; Congenital Erythropoietic Porphyria; erythropoietic protoporphyria; Next Generation Sequencing

Referências (se houver)

Fonte de Fomento (se houver)

Declaração de conflito de interesses de TODOS os autores

ão há conflitos de interesses dos autores referentes a essa apresentaçao

Área

Erros inatos do metabolismo